Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell × Ipilimumab × Clear all

Sponsor

Conditions

Melanoma 79 Carcinoma, Non-Small-Cell Lung 25 Neoplasms 18 Neoplasm Metastasis 13 Carcinoma, Renal Cell 13 Lung Neoplasms 11 Small Cell Lung Carcinoma 9 Prostatic Neoplasms 9 Diabetes Mellitus, Insulin-Dependent, 12 8 Pancreatic Neoplasms 7 Skin Neoplasms 6 Ovarian Neoplasms 6 Uveal Melanoma 5 Squamous Cell Carcinoma of Head and Neck 5 Mesothelioma 5 Brain Neoplasms 5 Sarcoma 4 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Colonic Neoplasms 3

Interventions

Cyclophosphamide 13 Etoposide 9 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Doxorubicin 7 Brentuximab Vedotin 7 romidepsin 6 fludarabine phosphate 6 Whole-Body Irradiation 6 Vincristine 6 Melphalan 6 fludarabine 5 Rituximab 5 Mycophenolic Acid 5 Granulocyte Colony-Stimulating Factor 4 Gemcitabine 4 Busulfan 4 10-propargyl-10-deazaaminopterin 4 pembrolizumab 3 etoposide phosphate 3 Tacrolimus 3 Lenalidomide 3 Filgrastim 3 Cytarabine 3 Carmustine 3 Antilymphocyte Serum 3 thymoglobulin 2 prednylidene 2 deltacortene 2 carmustine, poliferprosan 20 drug combination 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡